Life expectancy has soared and interest in the disease is growing, but breakthrough gene therapies are extraordinarily expensive.

Approximately 60% to 70% of patients aged 18 to 65 years will achieve a complete remission, but just 30.5% of these patients ...

Recent noteworthy reports on diffuse large B-cell lymphoma (DLBCL) include positive survival results with an antibody-drug ...

Knowable Magazine reports solid-state batteries promise improved EV performance with faster charging and longer ranges, but ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

The FDA has granted fast track designation to the investigational therapeutic agent WTX-124 for the potential treatment of ...

Optical diffraction tomography (ODT) has long been recognized for its potential in non-invasive, label-free imaging of live biological cells. However, a major challenge arises when ODT is applied to ...

Learn about pet bloodwork, the tests involved, and how to interpret results to ensure your furry friend's health. Read the ...

Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...

Experts from the International Solar Energy Society explain how regional spectral shifts of the standard spectral ...

Massload Technologies, Canada’s only VCAP-certified load cell manufacturer, is significantly expanding its engineering services across strategic USA markets, bringing four decades of specialized ...

Inarguably the most useful piece of technology widely used as an information gathering and sharing tool might be too ...